PTCT
Price:
$49.99
Market Cap:
$3.86B
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra...[Read more]
Industry
Biotechnology
IPO Date
2013-06-20
Stock Exchange
NASDAQ
Ticker
PTCT
According to PTC Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 48.38%. This represents a change of 290.86% compared to the average of 12.38% of the last 4 quarters.
The mean historical ROE of PTC Therapeutics, Inc. over the last ten years is -3662.26%. The current 48.38% ROE has changed -101.32% with respect to the historical average. Over the past ten years (40 quarters), PTCT's ROE was at its highest in in the March 2022 quarter at 139.90%. The ROE was at its lowest in in the December 2021 quarter at -9962.80%.
Average
-3662.26%
Median
-46.41%
Minimum
-36432.61%
Maximum
161.06%
Discovering the peaks and valleys of PTC Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.98%
Maximum Annual ROE = 161.06%
Minimum Annual Increase = -100.44%
Minimum Annual ROE = -36432.61%
Year | ROE | Change |
---|---|---|
2023 | 76.55% | -52.47% |
2022 | 161.06% | -100.44% |
2021 | -36432.61% | 39.98% |
2020 | -90.91% | 114.76% |
2019 | -42.33% | 15.91% |
2018 | -36.52% | -27.69% |
2017 | -50.50% | -57.51% |
2016 | -118.84% | 108.10% |
2015 | -57.11% | 81.80% |
2014 | -31.41% | -16.84% |
The current ROE of PTC Therapeutics, Inc. (PTCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12065.00%
5-year avg
-7265.65%
10-year avg
-3662.26%
PTC Therapeutics, Inc.’s ROE is less than Krystal Biotech, Inc. (6.34%), less than Sarepta Therapeutics, Inc. (11.83%), greater than Iovance Biotherapeutics, Inc. (-58.43%), greater than Madrigal Pharmaceuticals, Inc. (-71.78%), less than Reata Pharmaceuticals, Inc. (47.21%), greater than Intercept Pharmaceuticals, Inc. (-12.41%), greater than Blueprint Medicines Corporation (-47.66%), less than Viking Therapeutics, Inc. (0%), greater than Hepion Pharmaceuticals, Inc. (-12.73%), greater than null (-505.74%),
Company | ROE | Market cap |
---|---|---|
6.34% | $5.34B | |
11.83% | $12.10B | |
-58.43% | $2.62B | |
-71.78% | $6.82B | |
47.21% | $6.57B | |
-12.41% | $794.69M | |
-47.66% | $6.06B | |
0% | $5.33B | |
-12.73% | $4.38M | |
-505.74% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PTC Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PTC Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PTC Therapeutics, Inc.'s ROE?
How is the ROE calculated for PTC Therapeutics, Inc. (PTCT)?
What is the highest ROE for PTC Therapeutics, Inc. (PTCT)?
What is the 3-year average ROE for PTC Therapeutics, Inc. (PTCT)?
What is the 5-year average ROE for PTC Therapeutics, Inc. (PTCT)?
How does the current ROE for PTC Therapeutics, Inc. (PTCT) compare to its historical average?